Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
UltraCAR-T by SaxoCell for Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia): Likelihood of Approval
UltraCAR-T is under clinical development by SaxoCell and currently in Phase II for Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia)....